Factor viii assays in haemophilia a patients treated with refacto™

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|121|2|379-380

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.121, Iss.2, 2003-04, pp. : 379-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein

By  

HAEMOPHILIA, Vol. 24, Iss. 1, 2018-01 ,pp. : 77-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

MUTATIONS IN A SUBGROUP OF PATIENTS WITH MILD HAEMOPHILIA A AND A FAMILIAL DISCREPANCY BETWEEN THE ONE‐STAGE AND TWO‐STAGE FACTOR VIII:C METHODS

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 400-406

John Wiley & Sons Inc

Access to resources Recommend Favorite

MUTATIONS IN A SUBGROUP OF PATIENTS WITH MILD HAEMOPHILIA A AND A FAMILIAL DISCREPANCY BETWEEN THE ONE‐STAGE AND TWO‐STAGE FACTOR VIII:C METHODS

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 1996-08 ,pp. : 400-406

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epsilon-Aminocaproic Acid Inhibits the Activity of Factor VIII Inhibitors in Patients with Severe Haemophilia A in vivo and in vitro

By  

Acta Haematologica, Vol. 103, Iss. 2, 2000-05 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Allergic reaction in a cohort of haemophilia A patients using plasma‐derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII

By  

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : e281-e285

John Wiley & Sons Inc

Access to resources Recommend Favorite